DOCSLIB.ORG

Indian Entrepreneur Fund (I) Fund Factsheet I February 2013

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Indian Entrepreneur Fund (I) Fund Factsheet I February 2013 INDIAN ENTREPRENEUR FUND (I) FUND FACTSHEET I FEBRUARY 2013 Indian Entrepreneur Fund (IEF): Objective: Launched in March 2010, Indian Entrepreneur Fund aims to invest in “Entrepreneur run and/or family owned businesses”*; listed on the Indian stock markets, for compounding gains over the medium to long term. Indian Entrepreneur Fund aims to invest in high growth (listed) businesses owned and managed by Indian entrepreneurs/families for superior long term wealth creation. IEF will be a portfolio of 18-20 high growth, high quality businesses (mostly mid-size) led by entrepreneurs with vision and integrity, capable of at least doubling their bottom line in the next 3-4 year period. Research methodology and brief rationale: Our study covered the universe of Top 500 listed companies by market cap and we segregated them into four categories based on their ownership structures - Entrepreneur run/ Family Owned Businesses (FOBs), Public Sector Undertakings (PSUs), Multi National Corporations (MNCs) and Pure Professional Firms. Since the widely held professional firms were only a handful in number, the three categories were taken up for intensive analysis and compared against a host of criteria i.e. sales growth, profit growth, operating margins, capital efficiency – RoE & RoCE and wealth creation. In each of the above comparisons, the entrepreneur run/family owned businesses fared exceedingly well. The summary of the findings are as below: Following are the findings and salient features of the research on Indian Entrepreneur and for Family Owned Companies: § Continued Dominance of Entrepreneur / Family owned firms § Entrepreneur/Family Owned Firms comprise ~70% of India’s market cap (in 1999 it was ~60% ) § Fastest growing businesses § Both Sales and Profits grew at ~30% CAGR over last 8 years § Superior operating margins § Over 20% OPMs consistently since 2002 to 2011. § Improving capital efficiency § With rising turnover and profitability § Despite doubling the capital expenditure in the last 3 years § Most sunrise businesses in India are run by entrepreneurs § New age, cutting edge, innovation led businesses like Information Technology, Telecom, Pharmaceuticals etc. § Biggest wealth creators Portfolio Manager’s Commentary: After seeing off a slow start to the year in January, Indian equities were in for a month of weakness in February. The benchmark BSE 500 dropped 6.5%, while the drop in CNX Midcap Index was sharper at 9.8%. IEF with its focus on quality businesses, outperformed the benchmark significantly. Key action in the fund during the month was inclusion of PI Industries. Though we have booked some profits in Sun Pharma and Pidilite Industries, we continue to remain positive on these businesses, given the management pedigree, strong product profile and business characteristics. PI Industries’ is one of the leading players in the Crop protection industry. Company has a niche portfolio of 26 products, which includes 5-6 in-licensed products in tie up with MNCs such as Bayer, BASF & Kumiai chemicals. Unique business model, strong relationship with global innovators, good revenue visibility, well spread distribution network coupled with high business growth and attractive valuation make it a compelling investment case. Overall, during the month we have further increased the Agri weightage in the fund. We remain almost fully invested with bias towards quality companies that meet our filtering criteria. Each business in the fund has its unique strength and has significant ability to counter the market volatility. Top three sectors in the fund are FMCG, Healthcare and Banking. Fund Details Performance Snapshot (% US$) Investment geography India 2013 Since 1mth 3mth 6mth 1yr 2yr Investment style Long only (Feb YTD) inception Domicile Mauritius Indian Entrepreneur Fund (2) 1 13 2 1 1 9 Base currency US $ BSE 500 (7) (3) 12 (5) (12) (4) (13) NAV frequency Every Thursday Dividend policy None * Inception date 26th March 2010 Website www.ieof.com Sector allocation Top 10 holdings ISIN MU0185S00050 (Institutional A) MU0185S00068 (Institutional B) Sectors Portfolio Stock NAV (%) Bloomberg ticker code INDENI2MP (Institutional A) / (% ) INDENI1MP ( Institutional B) Healthcare 20.1 Sun Pharmaceutical Industries Ltd. 7.1 Fund Size (IEF) US $ 22 mn Auto 14.0 Divi's Laboratories Ltd. 6.7 Fund Size (IEOF) US $ 132 mn Financials 13.9 Asian Paints Ltd. 6.5 Materials 10.6 Bajaj Finserv Ltd. 6.4 NAV details as on 28 February, 2013 FMCG 10.4 Lupin Ltd. 6.4 NAV Retail 10.0 Pidilite Industries Ltd. 5.3 Class Fee Type ( US$ / Share ) Information Technology 7.6 Page Industries Ltd. 5.2 Chemicals 6.5 Shree Cement Ltd. 5.2 Institutional A Fixed 1.093 Consumer Discretionary 4.7 Kotak Mahindra Bank Ltd. 5.2 Institutional B Variable 1.105 CASH 2.2 Dabur India Ltd. 5.1 Note: Please refer to the terms of the fund overleaf. Total 100.0 Total 59.0 INDIAN ENTREPRENEUR FUND (I) FUND FACTSHEET I FEBRUARY 2013 Brief on top 5 companies l Sun Pharmaceuticals Industries Ltd. is a fully integrated pharma company with strong presence in the US, India and emerging markets. It derives around 40% revenues from the domestic market and has dominant position in specialty therapies such as CNS, CVS, Ophthalmology, Gynecology, Urology, Gastroenterology etc. Sun Pharma has delivered strong performance over last couple of years led by high exposure to chronic therapies and a strong track record in execution and is expected to continue going forward. Sun Pharma is also the largest Indian pharma company in the US and operates through Caraco, Taro and its own subsidiary. With turnaround seen in Taro, we expect US to remain the key growth driver over the next couple of years. Sun Pharma has entered into strategic tie-up with MSD which would augment its presence in emerging markets. With over 60% of revenues from overseas operations, Sun pharma is better placed to gain in coming years. We expect 18% revenue CAGR over FY12-14E for Sun driven by consolidation of Taro, strong growth in the US and domestic business. Sun has the best operating profit margins in the industry (30-35% range) and continues to sustain its margins through a focused approach. Sun Pharma has cash surplus close to INR 60bn and ROCE of +30%. l Divi's Laboratories Ltd. is a leading player in the CRAMS (Contract Research and Manufacturing Services) segment and has a strong CCS (Custom Synthesis segment) pipeline. It is well positioned in the global pharmaceutical outsourcing market as a research focused custom manufacturing player. About 47% of Divi’s revenues are derived from this segment while the balance is derived from generic exports. It has the first mover advantage to capture significant share of pharma outsourcing by innovator companies. Divi’s has a strong business model, best in class margins and return ratios, strong balance sheet. We expect Divi’s to be a key beneficiary of the increased pharmaceutical outsourcing from India given its strong relationships with global innovator pharmaceutical companies. l Asian Paints is the market leader in the US$3.8bn domestic decorative paints industry with ~60% market share (2.5x greater than the nearest competitor) and an unmatched distribution reach and a presence across price points. This dominant position translated into ROCEs of over 50% with high and consistent dividend payout ratio of ~40%. The decorative paint volumes continue to grow at 1.5 - 2x GDP led by up-trading from the non-branded segment, conversion of lime wash users, housing penetration and product innovations. With strong management capability and sound strategy we expect Sun Pharma to sustain high profitability going forward. l Bajaj Finserv Limited is the holding company of the following businesses: Life insurance, general insurance and consumer finance. Standalone BFL is into the business of wealth management and financial services distribution and operates windmills in Maharashtra. It’s a play on underpenetrated insurance sector in India. Growth to be driven by new product launches and strong agency network. Well established life insurance business, rapidly growing lending business, brand equity of Bajaj group and strong management team will be the key going forward. l Lupin Ltd. is a direct play on the evolving generic Pharma opportunity in both the developing world as well as the developed world. It has a consistent track record of steady growth in last few years. The company is strongly positioned in its top 3 markets of US, India & Japan where it is witnessing robust performance driven by healthy product pipeline and different strategies for each markets. Lupin is the 5th largest player in the Indian market growing above industry average rate. It has significant presence in the domestic market in therapeutic areas like cardiovascular, diabetology, asthma, pediatrics and CNS, besides holding global leadership position in anti TB and cephalosporins segments. Lupin has also made a foray in the export markets including US & Japan. It is the only Indian player to be present in the branded generic space in US. Acquisition of Kwoya Pharma in 2007 marked its entry into Japan, recent acquisition of I’rom Pharma would further consolidate its presence. Currently, Lupin is the largest Indian generic company in Japan and is much ahead on the curve in terms of product pipeline. With Lupin's strong pipeline of OC portfolio,pick up in US launches and steady growth in branded markets, we expect earnings growth of 25% cagr over FY12-14E Terms of the Fund Class Fee type Investment Amount Management Fees Performance fees** Institutional A Fixed 1.75%p.a. Nil US$1mn and above 1.00%p.a. Institutional B Variable 20% over 10% on XIRR basis at the end of 3 years Notes: l ** First Performance linked fees will be charged on 31st March 2013 or on early exit due to partial or full redemption whichever is earlier.
Load more

Recommended publications
  • Model Portfolio Update
    Model Portfolio update January 21, 2016 LatestDeal Team Model – PortfolioAt Your Service Large cap Midcap Name of the company Weightage(%) Name of the company Weightage(%) Auto 14 Aviation 6 Tata Motor DVR 4 Interglobe Aviation 6 Bosch 3 Auto 6 Maruti 4 Bharat Forge 6 EICHER Motors 3 BFSI 6 BFSI 23 BjjFiBajaj Finserve 6 HDFC Bank 8 Capital Goods 6 Axis Bank 3 HDFC 8 Bharat Electronics 6 Bajaj Finance 4 Cement 6 Capital Goods 5 Ramco Cement 6 L & T 5 Consumer 24 Cement 3 Symphony 6 UltraTech Cement 3 Supreme Ind 6 FMCG/Consumer 14 Kansai Nerolac 6 ITC 7 Pidilite 6 United Spirits 2 FMCG 8 Asian Paints 5 Nestle 8 IT 21 Infrastructure 8 Infosys 10 NBCC 8 TCS 8 Oil & Gas 6 Wipro 3 Meida 2 CtlCastrol 6 Zee Entertainment 2 Logistics 6 Metal 2 Container Corporation of India 6 Tata Steel 2 Pharma 12 Oil & Gas 4 Natco Pharma 6 Reliance Industries 4 Torrent Pharma 6 Pharma 12 Textile 6 Lupin 5 Arvind 6 Dr Reddys 4 Total 100 Aurobindo Pharma 3 Total 100 • Exclusion - Eicher Motors, Bajaj Finance (transferred to large cap), PVR, • Exclusion- State Bank of India, Bharti Airtel and ONGC CARE, Cummins & Shree Cement • Inclusion – Eicher Motors, Bajaj Finance (transferred from midcap), Wipro, • Inclusion – Ramco Cement, Bajaj Finserv, Supreme Industries, Indigo, Reliance Industries & Aurobindo Pharma Pidilite, Bharat Electronics and Bharat Forge Source: Bloomberg, ICICIdirect.com Research *Diversified portfolio - Combination of 70% large cap and 30% midcap portfolio OutperformanceDeal Team – At continues Your Service across all portfolios… • Our indicative large cap equity model portfolio (“Quality -20”) has • In the large cap space we continue to remain positive on pharma & IT.
    [Show full text]
  • Annexure to the Board Report | L&T Annual Report 2019-20
    Annexure ‘A’ to the Board Report and EnPI reduction of CG moulding energy consumption. Information as required to be given under Section 134(3) zz Implemented Smart COMM Energy Management (m) read with Rule 8(3) of the Companies (Accounts) system at ASW & Digital Dashboard. Rules, 2014. zz Replacement of conventional light fittings with [A] CONSERVATION OF ENERGY: Solar lighting system in SSII, Open yard-5 and (i) Steps taken or impact on conservation of Grit blasting & painting areas at Production/ energy: Utility areas at EWL Kancheepuram factory and Kansbahal works. zz Implementation of LED lights in HE-Hazira campus and other project sites and Solar Pipes in zz Replacement of conventional MH Lamps and SG fabrication area. fluorescent tube lights by LED lamps in working areas at office and projects as well as for street zz Installation of an Off Grid Mini-Solar Power Plant for meeting the energy requirement of site & lights. workmen habitats at Ranchi Smart City Project. zz Installation of energy efficient water coolers and submersible pumps zz Installed Local Pre/ Post Weld Heat Treatment (PWHT) using PID Technology which ensures zz Replacing existing aged inefficient Split AC units uniform heating and reduction in energy with energy efficient units wastage. zz Utilization of Chiller for HVAC System – Campus zz Implemented the use of Metal Halide (400 Watt) FMD initiated and control the chiller running EOT Crane under bay lights with LED Lights. hour for HVAC need during holidays and extended working hours. zz Installed Energy efficient burners for Furnaces and pre heating. zz Initiative has been taken for replacement of Air-Cooled Chiller with Water Cooled Chiller.
    [Show full text]
  • List of Nodal Officer
    List of Nodal Officer Designa S.No tion of Phone (With Company Name EMAIL_ID_COMPANY FIRST_NAME MIDDLE_NAME LAST_NAME Line I Line II CITY PIN Code EMAIL_ID . Nodal STD/ISD) Officer 1 VIPUL LIMITED [email protected] PUNIT BERIWALA DIRT Vipul TechSquare, Golf Course Road, Sector-43, Gurgaon 122009 01244065500 [email protected] 2 ORIENT PAPER AND INDUSTRIES LTD. [email protected] RAM PRASAD DUTTA CSEC BIRLA BUILDING, 9TH FLOOR, 9/1, R. N. MUKHERJEE ROAD KOLKATA 700001 03340823700 [email protected] COAL INDIA LIMITED, Coal Bhawan, AF-III, 3rd Floor CORE-2,Action Area-1A, 3 COAL INDIA LTD GOVT OF INDIA UNDERTAKING [email protected] MAHADEVAN VISWANATHAN CSEC Rajarhat, Kolkata 700156 03323246526 [email protected] PREMISES NO-04-MAR New Town, MULTI COMMODITY EXCHANGE OF INDIA Exchange Square, Suren Road, 4 [email protected] AJAY PURI CSEC Multi Commodity Exchange of India Limited Mumbai 400093 0226718888 [email protected] LIMITED Chakala, Andheri (East), 5 ECOPLAST LIMITED [email protected] Antony Pius Alapat CSEC Ecoplast Ltd.,4 Magan Mahal 215, Sir M.V. Road, Andheri (E) Mumbai 400069 02226833452 [email protected] 6 ECOPLAST LIMITED [email protected] Antony Pius Alapat CSEC Ecoplast Ltd.,4 Magan Mahal 215, Sir M.V. Road, Andheri (E) Mumbai 400069 02226833452 [email protected] 7 NECTAR LIFE SCIENCES LIMITED [email protected] SUKRITI SAINI CSEC NECTAR LIFESCIENCES LIMITED SCO 38-39, SECTOR 9-D CHANDIGARH 160009 01723047759 [email protected] 8 ECOPLAST LIMITED [email protected] Antony Pius Alapat CSEC Ecoplast Ltd.,4 Magan Mahal 215, Sir M.V. Road, Andheri (E) Mumbai 400069 02226833452 [email protected] 9 SMIFS CAPITAL MARKETS LTD.
    [Show full text]
  • Havells India (HAVIND)
    Havells India (HAVIND) CMP: | 1031 Target: | 1215 (18%) Target Period: 12 months BUY May 22, 2021 Strong recovery across product segments... Havells continued its growth momentum in Q4FY21 with topline growth of 50% YoY in line with our estimate of 48%. The company witnessed strong Particulars revenue growth in all business verticals cables, switchgears, electrical Particular Amount consumer durable (ECD), Lloyd, lightings and others by 51%, 53%, 71%, Market Capitalization (| Cr) 64,324.1 29%, 40% and 71%, respectively. The management reiterated market share Total Debt (FY21) (| Cr) 393.7 gains, strong demand traction in rural helped drive sales recovery for Havells Cash and Inv (FY21) (| Cr) 1,931.0 India in Q4 and in FY21. The company reported ~11% topline growth in EV (| Cr) 62,786.7 FY21 despite a washout in Q1. The key takeaways from conference call are: 52 week H/L 1238 / 454 Equity capital (| Cr) 62.6 Update Result 1) strong sales traction in first two weeks of April 2021 before lockdown Face value (|) 1.0 sseSFsfsf imposed in many states, 2) May sales hit by lockdown across the country, 3) price hikes of 10% in fans and 45-50% in cable business to offset Price Performance sseSFsfsf inflationary pressure, 4) focus on capacity building of Lloyd (future launches in refrigerators and washing machines categories), 5) focus on tapping rural 1400 20000 1200 and semi urban markets for the long term. However, considering lockdowns 1000 15000 and higher input prices, we revise our FY22E revenue, PAT estimate 800 10000 downward by ~7%, 6%, respectively. 600 400 5000 200 Strong b/s helps navigate challenging scenario 0 0 Havells India reported revenue, PAT CAGR of ~13%, ~15%, respectively, in Oct-18 Apr-21 Jan-20 Jun-20 Dec-17 Nov-20 Aug-19 Mar-19 the last 10 years with EBITDA margin expansion of 200 bps YoY to 15%.
    [Show full text]
  • Avenue Supermarts (DMART IN)
    Avenue Supermarts (DMART IN) Rating: BUY | CMP: Rs3,378 | TP: Rs3,686 July 10, 2021 Rising Footfalls, Online scalability Positive Q1FY22 Result Update Quick Pointers: Change in Estimates | ☑ Target | Reco . Q1FY22 saw a stronger second wave resulting in loss of more days or higher restriction on number of hours of store operations. Change in Estimates Current Previous . No significant impact on supply chain during the quarter, Inventory moving FY22E FY23E FY22E FY23E Rating BUY BUY towards normal levels. Target Price 3,686 3,366 Sales (Rs. m) 2,89,846 4,08,606 2,89,846 4,08,606 D’Mart 1Q results depicted impact of a strong second wave with business % Chng. - - EBITDA (Rs. m) 23,781 37,290 23,781 37,290 loss of more days (versus last year) and higher restriction on operating hours % Chng. - - /non-essential sales. However, rising footfalls, vaccination drive, 203% sales EPS (Rs.) 22.5 36.0 22.5 36.0 % Chng. - - growth in D’Mart ready and work on new store openings is positive. Key Financials - Consolidated Despite near term challenges we remain optimistic about the long term Y/e Mar FY20 FY21 FY22E FY23E potential of D’Mart on back of 1) Increasing scale and scope D’Mart Ready 2) Sales (Rs. m) 2,48,702 2,41,431 2,89,846 4,08,606 Extending offerings on D’Mart ready app to include general merchandise, EBITDA (Rs. m) 21,284 17,431 23,781 37,290 fresh food and vegetable 3) Growth in General merchandise sales over lower Margin (%) 8.6 7.2 8.2 9.1 PAT (Rs.
    [Show full text]
  • Indigo Paints Ltd
    Stock Idea Sector: Consumer Goods August 23, 2021 Indigo Paints Ltd Paint your portfolio bright Powered by Sharekhan’s 3R Research Philosophy Indigo Paints Ltd Paint your portfolio bright Stock Idea Stock Powered by the Sharekhan 3R Research Philosophy Consumer Goods Sharekhan code: INDIGOPNTS Initiating Coverage 3R MATRIX + = - Summary We initiate coverage on Indigo Paints Ltd (IPL) with a Buy and assign a target price of Rs. 3,305. Right Sector (RS) ü Differentiated business model, excellent return profile and strong structural growth outlook will keep valuation at a premium of 60x/44x its FY2023/24E earnings versus peers. Right Quality (RQ) ü With a differentiated product portfolio and bottom-up approach, IPL is emerging as one of India’s fastest growing paints companies. Revenues and PAT clocked a CAGR of 22% and 71% over FY2018-21. Right Valuation (RV) ü Gross margins are highest among peers at ~48% led by IPL’s locational advantage and healthy mix of revenues from differentiated products. + Positive = Neutral - Negative Better working capital management has kept net working capital cycle low at 13-14 days. Operating cash flows (OCF) improved from Rs. 42.8 crore to Rs. 101.4 crore over FY2019-21. Reco/View Indigo Paints Limited (IPL) is an emerging player, which has created a niche for itself in the highly competitive paints industry by launching differentiated products, creating brand equity through one prominent brand ‘Indigo’ and follow bottoms-up approach to expand its distribution in the Reco: Buy domestic market. It has market share of 2% but has strong potential to improve it in the coming years.
    [Show full text]
  • Srinivas University M Ba I Year (2017-2019 Batch)
    SRINIVAS UNIVERSITY M BA I YEAR (2017-2019 BATCH) INDUSTRY ANALYSIS COLLEGE OF BUSINESS MANAGEMENT AND COMMERCE SL . REG. NO. STUDENT NAM E INDUSTRY ANALYSIS NO. INDIAN OIL 1 2017MBARG101 ABDUL AKHIL VOLTAS LTD CORPORATION LTD HOUSING AND URBAN RELIANCE INDUSTRIES 2 2017MBARG102 ABDUL RAVUF DEVELOPMENT LTD CORPORATION LTD STERLITE 3 2017MBARG103 AHMAD MUBSHER STATE BANK OF INDIA TECHNOLIGIES LTD AKSHATA LAXMAN SHIPPING 4 2017MBARG104 TATA MOTERS LTD NAYAK CORPORATION LTD GREAT EASTERN 5 2017MBARG105 AMAL S V RAJESH EXPORT LTD SHIPPING LTD 6 2017MBARG107 ANUSH RAJ BHARATH PETROLIUM KARNATAKA BANK LTD ARPITA NAGAPPA OIL AND NATURAL GAS 7 2017MBARG108 D S M SHRIRAM LTD HOSALLI CORPORATION LTD 8 2017MBARG109 ARUN RAJ COAL INDIA LTD ASAHI INDIA GLASS LTD TATA CONSULTENCY 9 2017MBARG110 AZEEM SHESHAD N M SPML INFRA LTD SERVICE LTD AZIZAHMAD IBRAHIM UNITED BANK OF INDIA 10 2017MBARG111 P & G LTD TANJI LTD 11 2017MBARG112 CHETHANA TATA STEEL LTD CEAT LTD LARSEN AND TOUBRO INFINITE COMPUTER 12 2017MBARG113 DEEKSHITH POOJARY LTD SOLUTIONS(INDIA LTD) HINDALCO INDUSTRIES PIDILITE INDUSTRIES 13 2017MBARG114 DEEPIKA P LTD LTD 14 2017MBARG115 DENSIL GEORGE BHARTI AIRTEL LTD KUSHAL LTD 15 2017MBARG116 DHANYASHREE K HDFC BANK LTD CASTROL INDIA LTD MAHINDRA & 16 2017MBARG117 DILSHANA K AIA ENGINEERING LTD MAHINDRA LTD FATHIMATH RAHEEMA ENDURANCE 17 2017MBARG118 NTPC LTD K TECHNOLOGY MAHINDRA CIE 18 2017MBARG119 FREDIN DOMINIC RELIANCE POWER LTD AUTOMOTIVE LTD GAYATRI GAJANANA RAYMOND COMPANY 19 2017MBARG120 INFOSYS LTD PAI LTD MARUTI SUZUKI INDIA AMARA
    [Show full text]
  • Sharekhan Special August 31, 2021
    Sharekhan Special August 31, 2021 Index Q1FY2022 Results Review Automobiles • Capital Goods • Consumer Discretionary • Consumer Goods • Infrastructure/Cement/Logistics/Building Material • IT • Oil & Gas • Pharmaceuticals • Agri Inputs and Speciality Chemical • Miscellaneous • Visit us at www.sharekhan.com For Private Circulation only Q1FY2022 Results Review In-line quarter, healthy outlook Results Review Results Summary: After ending FY2021 on a strong note, Q1FY2022 earnings of broader indices showed a promising start (Nifty/ Sensex companies’ PAT rose 100%/66% y-o-y) in the new fiscal with strong growth momentum on low base. Management commentaries on earnings outlook remained positive, on improving economic activity post second COVID-19 wave and anticipation of strong demand revival. Demand recovery and ramp-up of vaccinations look encouraging. We expect economic activity to increase in the upcoming festive season. Nifty trades at 23x and 20x EPS based on FY2022E/FY2023E EPS, at a premium to mean average. Valuation gap between large and mid-caps has shrunk, we advise investors to focus on stocks with strong earnings growth potential with reasonable valuation. High-conviction investment ideas: o Large-caps: Infosys, ICICI Bank, M&M, L&T, UltraTech, SBI, HDFC Ltd, Godrej Consumer Products, Divis Labs and Titan. o Mid-caps: NAM India, BEL, Gland Pharma, Dalmia Bharat, Laurus Labs, Max Financial Services, LTI. o Small-caps: TCI Express, Kirloskar Oil, Suprajit Engineering, Repco Home Finance, PNC Infratech, Mahindra Lifespaces, Birlasoft. After ending FY2021 on a strong note, Q1FY2022 corporate earnings of broader indices showed a promising start with continued strong growth momentum on the low base of Q1FY2021, though it was along the expected lines.
    [Show full text]
  • S.No. Scrip Name Symbol Series Leverage (In Times) 1 MARICO
    SCRIPS AVAILABLE FOR INTRADAY WITH LEVERAGES PROVIDED ON THEM Leverage Scrip Name Symbol Series (in times) S.No. 1 MARICO LIMITED MARICO 7.61 2 DABUR INDIA LIMITED DABUR 7.92 3 HINDUSTAN UNILEVER LIMITED HINDUNILVR 7.48 4 COLGATE PALMOLIVE (INDIA) LIMITED COLPAL 7.48 5 NESTLE INDIA LIMITED NESTLEIND 7.39 6 Alkem Laboratories Limited ALKEM 6.91 7 TATA CONSULTANCY SERVICES LIMITED TCS 7.24 8 DR. REDDY'S LABORATORIES LIMITED DRREDDY 6.54 9 PIDILITE INDUSTRIES LIMITED PIDILITIND 7.07 10 GODREJ CONSUMER PRODUCTS LIMITED GODREJCP 5.79 11 POWER GRID CORPORATION OF INDIA LIMITED POWERGRID 6.46 12 ACC LIMITED ACC 6.61 13 NTPC LIMITED NTPC 6.64 14 ITC LIMITED ITC 7.05 15 ASIAN PAINTS LIMITED ASIANPAINT 6.52 16 BRITANNIA INDUSTRIES LIMITED BRITANNIA 6.98 17 BERGER PAINTS (I) LIMITED BERGEPAINT 6.78 18 EXIDE INDUSTRIES LIMITED EXIDEIND 6.89 19 HDFC BANK LIMITED HDFCBANK 6.63 20 DIVI'S LABORATORIES LIMITED DIVISLAB 6.69 21 MRF LIMITED MRF 6.73 22 INDIAN OIL CORPORATION LIMITED IOC 6.49 23 BAJAJ AUTO LIMITED BAJAJ-AUTO 6.64 24 SIEMENS LIMITED SIEMENS 6.40 25 THE RAMCO CEMENTS LIMITED RAMCOCEM 6.23 26 TORRENT POWER LIMITED TORNTPOWER 6.10 27 UNITED BREWERIES LIMITED UBL 6.16 28 INFOSYS LIMITED INFY 6.82 29 CIPLA LIMITED CIPLA 6.52 30 Pfizer Limited PFIZER 6.41 31 PETRONET LNG LIMITED PETRONET 6.45 32 UNITED SPIRITS LIMITED MCDOWELL-N 6.24 33 CADILA HEALTHCARE LIMITED CADILAHC 5.97 34 WIPRO LIMITED WIPRO 6.10 35 SUN PHARMACEUTICAL INDUSTRIES LIMITED SUNPHARMA 6.18 36 BATA INDIA LIMITED BATAINDIA 6.44 37 LARSEN & TOUBRO LIMITED LT 6.38 38 ULTRATECH CEMENT
    [Show full text]
  • Consumer Durables22apr21
    Consumer Durables Sector Update April 26, 2021 PLI to foster component ecosystem Government has approved the Production Linked Incentive (PLI) Scheme for Air Conditioners and LED Lights to be implemented over FY22 to FY29 with a PL Universe budgetary outlay of Rs62.4bn (4-6% incentive on incremental sales over base year FY20). Given the contours of the scheme, we believe this shall promote Companies Rating CMP (Rs) TP (Rs) onshore manufacturing of critical components like Compressors, Motors, PCBs, LED chips amongst others. We remain unsure on the participation of Bajaj Electricals BUY 1,135 1,033 CG Cons. Elec. BUY 354 447 local brands like Voltas, Havells etc. given the capital intensive nature and Havells India Hold 1,006 1,128 need of large economies of scale for these components. Nevertheless, Polycab India BUY 1,485 1,480 creation of a robust component ecosystem by ancillary entities remains a Voltas Hold 939 1,000 positive for brands as it shall help 1) accelerate import substitution and 2) Source: PL shrink lead times thereby reducing working capital requirements. We continue to maintain our positive stance on consumer durables space given huge penetration scope and market consolidation. Amongst our coverage universe, Voltas/ Lloyd (Havells) stand to benefit from AC PLI while Crompton, Havels, Bajaj and Polycab to benefit from the LED Lights PLI. Key Highlights of the Scheme: . To incentivize manufacturing of components of Air Conditioners and LED Lights over FY22-FY29 with a budgetary outlay of Rs62.4bn. Categories within Air Conditioner: . AC Components: High Value Intermediates or Low Value Intermediates or Sub-assemblies or a Combination thereof .
    [Show full text]
  • Inner 32 Arbitrage Fund Low
    Tata Arbitrage Fund (An open ended scheme investing in arbitrage opportunities.) As on 30th April 2020 PORTFOLIO % to % to NAV % to % to NAV Company name Company name INVESTMENT STYLE NAV Derivative NAV Derivative The scheme invests in equity and equity related instruments that tries Hedge Positions 67.99 -68.10 ACC Ltd. 0.28 -0.28 to take advantage of the difference in prices of a security in the cash Infosys Ltd. 2.28 -2.28 Mahindra & Mahindra Ltd. 0.28 -0.28 segment and derivatives segment by turning market volatility to its State Bank Of India 2.15 -2.15 Indraprastha Gas Ltd. 0.28 -0.28 advantage. Housing Development Finance Corporation Ltd. 1.89 -1.89 HCL Technologies Ltd. 0.24 -0.24 Tata Consultancy Services Ltd. 1.83 -1.82 Bharat Heavy Electricals Ltd. 0.24 -0.24 INVESTMENT OBJECTIVE Cipla Ltd. 1.75 -1.75 Godrej Properties Ltd. 0.23 -0.23 The investment objective of the Scheme is to seek to generate Adani Ports And Special Economic Zone Ltd. 1.72 -1.72 Colgate-Palmolive India Ltd. 0.20 -0.20 Dr Reddys Laboratories Ltd. 1.71 -1.71 Berger Paints India Ltd. 0.20 -0.20 reasonable returns by investing predominantly in arbitrage Reliance Industries Ltd. 1.63 -1.64 Bharat Electronics Ltd. 0.19 -0.19 opportunities in the cash and derivatives segments of the equity Bharti Airtel Ltd. 1.62 -1.62 Bharat Petroleum Corporation Ltd. 0.18 -0.18 markets and by investing balance in debt and money market Hindustan Petroleum Corporation Ltd.
    [Show full text]
  • 1 Reliance Industries Limited 2 Tata Consultancy Services (TCS)
    1 Reliance Industries Limited 2 Tata Consultancy Services (TCS) 3 Infosys Technologies Ltd 4 Wipro Limited 5 Bharti Tele-Ventures Limited 6 ITC Limited 7 Hindustan Lever Limited 8 ICICI Bank Limited 9 Housing Development Finance Corp. Ltd. 10 TATA Steel Limited 11 Ranbaxy Laboratories Limited 12 HDFC Bank Ltd 13 Tata Motors Limited 14 Larsen & Toubro Limited (L&T) 15 Satyam Computer Services Ltd. 16 Maruti Udyog Limited 17 Bajaj Auto Ltd. 18 HCL Technologies Ltd. 19 Hero Honda Motors Limited 20 Hindalco Industries Ltd 21 Reliance Energy Limited 22 Grasim Industries Limited 23 Jet Airways (India) Ltd. 24 Sun Pharmaceuticals Industries Ltd 25 Cipla Ltd. 26 Gujarat Ambuja Cements Ltd. 27 Videsh Sanchar Nigam Limited 28 The Tata Power Company Limited 29 Sterlite Industries (India) Ltd. 30 Associated Cement Companies Ltd. 31 Nestlé India Ltd. 32 Hindustan Zinc Limited 33 GlaxoSmithKline Pharmaceuticals Limited 34 Siemens India Ltd. 35 Motor Industries Company Limited 36 Mahindra & Mahindra Limited 37 UTI Bank Ltd. 38 Zee Telefilms Limited 39 Bharat Forge Limited 40 ABB Limited 41 i-Flex Solutions Ltd. 42 Dr. Reddy's Laboratories Ltd. 43 Nicholas Piramal India Limited 44 Kotak Mahindra Bank Limited 45 Reliance Capital Ltd. 46 Ultra Tech Cement Ltd. 47 Patni Computer Systems Ltd. 48 Wockhardt Limited 49 Indian Petrochemicals Corporation Limited 50 Biocon India Limited 51 Essar Oil Limited. 52 Asian Paints Ltd. 53 Dabur India Limited 54 Jaiprakash Associates Limited 55 JSW Steel Limited 56 Tata Chemicals Limited 57 Tata Tea Limited 58 Tata Teleservices (Maharashtra) Limited 59 The Indian Hotels Co. Ltd. 60 Glenmark Pharmaceuticals Limited 61 NIRMA Limited 62 Jindal Steel & Power Ltd 63 HCL Infosystems Ltd.
    [Show full text]